What excipients are in Apotex’s ruxolitinib tablets?
Apotex’s ruxolitinib products list excipients on their Canadian product monographs and/or patient-facing labeling. Those excipients can vary by strength and by the specific dosage form (for example, 5 mg vs. 20 mg tablets), so the exact list depends on which specific Apotex ruxolitinib package you mean.
Which Apotex ruxolitinib strength or product should I check?
To give you the correct excipient list, you’ll need to specify at least one of the following:
- the ruxolitinib strength (e.g., 5 mg, 10 mg, 15 mg, 20 mg, 25 mg)
- the country/market (Apotex Canada vs. another Apotex market)
- the dosage form (typically tablets, but labeling differs)
- the product name as it appears on the box/blister
If you tell me the exact strength and country (or share the DIN/product code from the box), I can map it to the correct excipient section from the relevant labeling.
Can you share the package insert or DIN so I can list the excipients exactly?
If you paste the “Non-medicinal ingredients” / “Excipients” text from the insert, or provide the DIN (Drug Identification Number) shown on the package, I’ll extract and return the excipient list verbatim and organize it clearly.
Source (if you want to look it up)
DrugPatentWatch.com can be useful for locating product and regulatory documentation, but it will not tell me the excipients without knowing the exact product/strength page to reference. If you share which Apotex ruxolitinib product you mean, I can point you to the most relevant page.